Technology | Ultrasound Imaging | February 28, 2017

Philips Receives FDA 510(k) Clearance to Market ElastQ Imaging Shear Wave Elastography

ElastQ complements Philips' existing ultrasound offerings with non-invasive assessment of tissue stiffness to provide comprehensive solution for liver disease assessment, treatment and monitoring

Philips, FDA 510k clearance, ElastQ Imaging, shear wave elastography, ultrasound, liver tissue stiffness

February 28, 2017 — Philips announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ElastQ Imaging capability, further expanding the functionalities of its Epiq family of ultrasound systems.

ElastQ Imaging enables simultaneous imaging of tissue and assessment of its stiffness, which is essential for the diagnosis of various liver conditions. With ElastQ Imaging, clinicians have a comprehensive solution to assess and diagnose liver conditions without the pain or expense of a liver biopsy.  Using shear wave elastography to focus sound waves to assess soft tissue stiffness, ElastQ Imaging is non-invasive, reproducible and easily executed.

Liver disease, which includes hepatitis B and C, liver cancer and cirrhosis, is a growing global health issue due in part to rising obesity rates and an aging population. Non-alcoholic fatty liver disease affects approximately 20 percent of the global population [1]. According to the World Health Organization (WHO), total deaths worldwide from cirrhosis and liver cancer rose by 50 million per year over the last two decades, and many cases continue to go undetected [2].

To determine the stage of liver disease and damage, a liver biopsy is typically performed by extracting a small piece of liver tissue for microscopic examination. Research suggests that instead of costly and painful biopsy procedures, ultrasound exams using shear wave elastography could become routine for assessing liver disease status and may reduce or avoid the need for conventional liver biopsies [3].

Philips ElastQ Imaging shear wave elastography offers:

  • Larger field of view or region of interest (ROI) than competitors, according to Philips;
  • Color-coded quantitative assessment of tissue stiffness;
  • Real-time feedback and intelligent analysis; and
  • Quantitative measurements with multiple sample points.

In addition to ElastQ Imaging, Philips' ultrasound liver solution is comprised of a suite of features that make it a powerful tool for clinicians, including: 

  • PureWave transducer technology, delivering superb image quality and increased penetration in technically difficult-to-image patients;
  • Contrast enhanced ultrasound, providing confidence in liver lesion detection and characterization; and
  • Image fusion and navigation with anatomical intelligence, increasing the power of real-time ultrasound exams through multimodality fusion and interventional guidance.

Philips’ ultrasound liver solution combines a routine ultrasound imaging exam of the liver anatomy with targeted tissue stiffness values, allowing clinicians to obtain a baseline assessment without the wait time associated with tissue biopsy. For patients, the non-invasive ultrasound exam is more comfortable than a traditional liver biopsy that requires the use of needles. The exam results from ultrasound are also available instantly, which can help reduce apprehension patients may feel in waiting for test results.

"There is a significant population at risk for liver disease that may not even know it," said Richard G. Barr, M.D., Ph.D., radiologist, Southwoods Imaging, in Youngstown, Ohio. "As a radiologist, I see every day how important liver assessment is becoming, and I'm hopeful that this solution will help patients get the diagnosis, monitoring and treatment they need."

For more information: www.philips.com

References

[1] Sattar N, et al. Non-alcoholic fatty liver disease. BMJ 2014;349:g4596. 34 Dyson J et al. Non-alcoholic fatty liver disease: a practical approach to treatment. Postgrad Med J. 2015 Feb;91(1072):92-101.
[2] (2013, November 4). Global Burden of Liver Disease Substantial. Medscape. Retrieved from http://www.medscape.com/viewarticle/813788#vp_1 
[3] Ferraioli G, et al. Point shear wave elastography method for assessing liver stiffness. World J Gastroenterology. 2014 April 28;20(16):4787-4796.

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Sponsored Content | Videos | Ultrasound Imaging | January 06, 2020
The Arietta 850SE provides facilities with numerous features and functionality to get the most out of a system.
The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fufifilm capture a parger portion of international radiology market share. Photo by Dave Fornell.

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fujifilm capture a larger portion of international radiology market share. Photo by Dave Fornell.

Feature | Radiology Business | December 17, 2019 | Dave Fornell, Editor
December 17, 2019 — It was disclosed today that Fujifilm may buy Hitachi's diagnostic imaging business in a deal that
MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier